EDITAS MEDICINE, INC. Operating Leases, Future Minimum Payments, Due in Three Years
EDITAS MEDICINE, INC. (EDIT) had Operating Leases, Future Minimum Payments, Due in Three Years of $4.16 million as of 2016-12-31, per its 10-K filed 2017-03-03.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2017-03-03
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $4.16M.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2016-12-31 | $4.16M 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |